Uncover key drivers, emerging technologies, and competitive movements shaping the metaverse retail market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Bioabsorbable Stents Market’s size between 2026 and 2030?
The bioabsorbable stents market size has experienced rapid growth in recent years. This market is projected to expand from $0.41 billion in 2025 to $0.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.3%. Historically, this expansion can be linked to factors such as the rising incidence of cardiovascular diseases, the increasing uptake of interventional cardiology procedures, the initial application of biodegradable polymers in medical implants, the surge in coronary stent procedures, and continuous advancements in vascular intervention techniques.
The bioabsorbable stents market is projected to experience significant growth in the coming years, with its size expected to reach $0.65 billion by 2030, at a compound annual growth rate (CAGR) of 9.5%. This growth in the forecast period can be attributed to several factors, including an increasing demand for temporary vascular support solutions, a rising focus on long-term patient outcomes, the expansion of peripheral artery disease treatments, growing investments in biodegradable implant research, and increasing regulatory approvals for novel stent materials. Major trends anticipated during this period include the accelerated development of next-generation bioabsorbable materials, a rising adoption of polymer-based bioabsorbable stents, an intensified focus on reducing long-term complications, the expansion of clinical trials for peripheral applications, and an enhanced emphasis on biocompatibility and safety.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp
Which Drivers Are Shaping Strategic Decisions In The Bioabsorbable Stents Market?
The expanding incidence of heart failure is anticipated to fuel the expansion of the bioabsorbable stents market. This condition, marked by the heart muscle’s diminished capacity to effectively circulate blood and subsequent fluid buildup in the body, can be managed with bioabsorbable stents. These devices improve cardiac function and alleviate associated symptoms. For example, the Heart and Stroke Foundation of Canada, a Canada-based provider of information on stroke, heart disease, surgeries, and treatments, currently identifies 750,000 individuals living with heart failure, with 100,000 new cases of this irreversible ailment reported each year. By 2030, it is projected that healthcare costs associated with heart failure in Canada will amount to $2.8 billion per annum. Consequently, the rising prevalence of heart failure is expected to drive the future growth of the bioabsorbable stents market. The increasing number of older adults is predicted to stimulate the expansion of the bioabsorbable stents market in the future. This demographic, typically comprising individuals aged 65 and above, is expanding as a result of extended life expectancy, propelled by advancements in healthcare that allow people to live longer. Bioabsorbable stents offer advantages to this older demographic because they progressively dissipate after re-establishing blood flow, thereby minimizing long-term complications and removing the requirement for permanent implants in elderly patients who are more prone to delayed adverse events. For instance, the World Health Organization, a US-based specialized health agency, reported in October 2025 that the global population of those aged 80 and older is forecast to triple by 2050, reaching approximately 426 million. Consequently, the expanding geriatric population is a key factor driving the growth of the bioabsorbable stents market.
What Segment Classifications Make Up The Bioabsorbable Stents Market?
The bioabsorbable stents market covered in this report is segmented –
1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents
2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents
3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases
Subsegments:
1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents
2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents
What Long-Term Trends Are Expected To Shape The Future Of The Bioabsorbable Stents Market?
Companies engaged in the bioabsorbable stents market are concentrating on developing novel technologies, such as the Latest Generation of Bioresorbable Cardiac Stent, to enhance their market profitability. This advanced class of bioresorbable cardiac stents refers to sophisticated medical devices intended for the treatment of coronary artery disease, fabricated from biodegradable materials that naturally dissolve over time after successfully maintaining arterial openness. For instance, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, recently obtained market approval for the world’s first next-generation fully bioresorbable cardiac stent from China’s National Medical Products Administration (NMPA). Firesorb, developed by MicroPort Scientific Corporation, is engineered to entirely dissolve within three years, which considerably lessens long-term complications such as thrombosis. Clinical trials involving 1,468 patients revealed impressive results, including a minimal thrombosis rate of 0.32% and a 4-year target lesion failure rate of merely 4.3%. Leading medical experts have lauded its innovative thin strut design and enhanced endothelial coverage compared to prior stent generations.
Which Major Firms Are Strengthening Their Position In The Bioabsorbable Stents Market?
Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The Bioabsorbable Stents Market?
North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Bioabsorbable Stents Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp
Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2026, By The Business Research Company
Portable Food Safety Detectors Global Market Report 2026
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Laboratory Accessories Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/laboratory-accessories-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company